The debut of a rational treatment for an inherited neuropathy?

Journal of Clinical Investigation

Volumn 121, Issue 12, 2011, Pages 4624-4627

  Scherer, Steven S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYSPHINGOLIPID; SERINE; SERINE PALMITOYLTRANSFERASE; SERINE PALMITOYLTRANSFERASE LONG CHAIN BASE SUBUNIT 1; SPHINGOLIPID; UNCLASSIFIED DRUG;

DEMYELINATION; DISEASE COURSE; DISEASE SEVERITY; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1; HUMAN; MISSENSE MUTATION; NERVE FIBER; NEUROPATHY; NONHUMAN; NOTE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; FEMALE; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES; HUMANS; MALE; NEUROTOXINS; SERINE; SPHINGOSINE;

EID: 84055217329     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI60511     Document Type: Note

References (16)

1. Kandel ER, Schwartz JP, Jessell TM. Principles of Neural Science. New York, New York, USA: Elsevier; 2000.
2. Salzer JL. Polarized domains of myelinated axons. Neuron. 2003;40(2):297-318. (Pubitemid 37244097)
3. Shy ME, Lupski JR, Chance PF, Klein CJ, Dyck PJ. Hereditary motor and sensory neuropathies: an overview of clinical, genetic, electrophysiologic, and pathologic features. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy. Philadelphia, Pennsylvania, USA: Saunders; 2005:1623-1658.
4. Timmerman V. Inherited Peripheral Neuropathies Mutation Database. Human Genome Variation Society web site. http://www.molgen.ua.ac. be/CMTMutations/. Updated February 17, 2011. Accessed September 23, 2011.
5. Latour P, et al. SIMPLE mutation analysis in dominant demyelinating Charcot-Marie-Tooth disease: three novel mutations. J Peripher Nerv Syst. 2006;11(2):148-155. (Pubitemid 43894082)
6. Saporta ASD, Sottile SL, Miller LJ, Feely SME, Siskind CE, Shy ME. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol. 2011;69(1):22-33.
7. Scherer SS, Wrabetz L. Molecular mechanisms of inherited demyelinating neuropathies. Glia. 2008;56(14):1578-1589.
8. Bejaoui K, et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet. 2001; 27(3):261-262. (Pubitemid 32201845)
9. Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer- Grumbach M, Nicholson GA. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet. 2001;27(3):309-312. (Pubitemid 32201853)
10. Rotthier A, et al. Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Amer J Hum Genet. 2010;87(4):513-522.
11. Houlden H, et al. Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I). Brain. 2006; 129(pt 2):411-425. (Pubitemid 43164365)
12. Nicholson GA, Dawkins JL, Blair IP, AuerGrumbach M, Brahmbhatt SB, Hulme DJ. Hereditary sensory neuropathy type I: Haplotype analysis shows founders in southern England and Europe. Amer J Hum Genet. 2001;69(3):655-659. (Pubitemid 32777704)
13. Gable K, Gupta SD, Han G, Niranjanakumari S, Harmon JM, Dunn TM. A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity. J Biol Chem. 2010;285(30):22846-22852.
14. Penno A, et al. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem. 2010;285(15):11178- 11187.
15. Eichler FS, et al. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1. J Neurosci. 2009;29(46):14646-14651.
16. Garofalo K, et al. Oral l-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J Clin Invest. 2011;121(12):4735-4745.